MedPath

Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac Damage

Phase 4
Conditions
Sleep Apnea Syndrome
Metabolic Syndrome
Cardiac Remodelling
Continuous Positive Airway Pressure Ventilation
Registration Number
NCT00517777
Lead Sponsor
Università degli Studi dell'Insubria
Brief Summary

To assess in moderate to severe Obstructive Sleep Apnea the effects of one year therapy with nighttime continuous positive airway pressure ventilation on the prevalence of metabolic syndrome and cardiovascular damage.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • moderate to severe sleep apnea syndrome
Exclusion Criteria
  • cardiovascular diseases (coronary artery disease, stroke, peripheral artery disease)
  • thyroid diseases
  • diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
metabolic syndromeone year
left ventricular massone year
diastolic functionone year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Insubria-Department of Clinical Medicine

🇮🇹

Varese, Italy

University of Insubria-Department of Clinical Medicine
🇮🇹Varese, Italy
© Copyright 2025. All Rights Reserved by MedPath